Diagnostic Imaging (DI) Market Size, Share, Trends and Analysis by Product Type, Region and Segment Forecast to 2033

Powered by

Access in-depth insight and stay ahead of the market

Accessing the in-depth insights from the ‘Diagnostic Imaging’ market report can help you:

  • Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments.
  • Identify competitors’ capabilities to stay ahead in the market.
  • Identify segments and get an understanding of various stakeholders.
  • Anticipate changes in demand and adjust business development strategies.
  • Identify potential regions and countries for growth opportunities.

How is our Diagnostic Imaging’ market report different from other reports in the market?

  • The report presents in-depth market sizing and forecasts at a segment level for more than 15 countries, including historical and forecast analysis for 2021-2033 for market assessment.
  • Detailed segmentation by:
    • Product – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents
    • Region – North America, Europe, Asia-Pacific, South & Central America, and Middle East & Africa
  • The report covers the key market drivers and challenges impacting the diagnostic imaging market.
  • The competitive landscape includes an overview and company share analysis by segment in the diagnostic imaging market that will help the stakeholders in the ongoing process of identifying, researching, and evaluating competitors, to gain insight to form their business strategies.
  • Competitive profiling and benchmarking of key companies in the market to provide a deeper understanding of industry competition.

We recommend this valuable source of information to anyone involved in:

  • Companies Offering Diagnostic Imaging Solutions
  • Consulting & Professional Services Firms
  • Researchers and Academics
  • Venture Capital/Equity Firms

To Get a Snapshot of the Diagnostic Imaging Market Report, Download a Free Sample

 

Diagnostic Imaging Market Report Overview

The global diagnostic imaging market will be valued at $36.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% over the forecast period. The market growth can be attributed to the rising prevalence of chronic diseases such as cancer and cardiovascular diseases, thereby increasing the demand for sophisticated diagnostic imaging technologies.

The diagnostic imaging market encompasses a wide range of medical devices and systems used for visualizing the internal structures and functions of the human body, aiding in the diagnosis, and monitoring of various medical conditions. This market’s products include X-ray machines, MRI (Magnetic Resonance Imaging) scanners, CT (Computed Tomography) scanners, ultrasound systems, nuclear medicine equipment, and others.

The market holds immense significance in the field of healthcare and medicine, as it plays a pivotal role in the diagnosis and treatment of a wide range of medical conditions. Diagnostic imaging provides essential information for treatment planning. Moreover, surgeons and other healthcare professionals rely on imaging results to understand the size, location, and extent of tumors or abnormalities, aiding in surgical precision and targeted therapies. Its importance extends across several dimensions, impacting patient care, medical research, and healthcare systems.

Diagnostic Imaging Market Outlook, 2021-2033

Diagnostic Imaging Market Outlook, 2021-2033

Buy the Full Report for Additional Insights on Diagnostic Imaging Market Forecast

Download a Free Sample

Diagnostic imaging techniques are largely non-invasive, reducing the need for exploratory surgeries and invasive procedures. This minimizes patient discomfort, recovery time, and healthcare costs. The diagnostic imaging market is integral to medical research and advancements. Imaging studies generate vast datasets that contribute to understanding diseases, treatment efficacy, and patient outcomes. This data is crucial for developing new therapies, drugs, and medical technologies.

Market Size (2023) $36.5 billion
Market Size (2033) $55.0 billion
CAGR (2023-2033) 4.2%
Forecast Period 2023-2033
Historic Data 2021-2022
Report Scope & Coverage Industry Overview, Market Dynamics, Regulatory Landscape, Reimbursement Scenario, Revenue Forecast, Regional Analysis, Competitive Landscape, Company Profiles
Product Type Angio Suites, Bone Densitometers, C-arms, Computed Tomography (CT) Systems, CT systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents
Regional Segment North America, Europe, Asia-Pacific, Central & South America, and Middle East & Africa
Key Companies Bayer AG, Canon Inc, Cardinal Health Inc, Fujifilm Holdings Corp, GE Healthcare, Hologic Inc, Koninklijke Philips NV, Neusoft Corp, Shimadzu Corp, and Siemens AG

Diagnostic Imaging Market Segmentation by Product Type

The DI market by product type is segmented into angio suites, bone densitometers, c-arms, CT systems, contrast media injectors, mammography equipment, MRI systems, nuclear imaging equipment, ultrasound systems, x-ray systems, contrast agents, and nuclear imaging agents. The nuclear imaging equipment segment is expected to be the fastest-growing product type segment, with a CAGR of over 7% during the forecast period.

The increasing demand for nuclear imaging equipment in the field of diagnostic imaging represents a significant trend and development in healthcare. Nuclear imaging is a specialized branch of medical imaging that uses radioactive materials or radiopharmaceuticals to visualize and assess the functioning of organs and tissues within the body.

Nuclear imaging techniques such as SPECT (Single Photon Emission Computed Tomography) and PET (Positron Emission Tomography) can help evaluate brain function and detect neurological disorders like Alzheimer’s disease, epilepsy, and brain tumors. Moreover, nuclear imaging often guides minimally invasive procedures, such as radioactive iodine therapy for thyroid cancer or sentinel lymph node mapping in breast cancer surgery.

Diagnostic Imaging Market Share by Product Type, 2023 (%)

Diagnostic Imaging Market Share by Product Type, 2023 (%)

Buy the Full Report for Segment-Specific Revenues and Shares

Download a Free Sample

The ultrasound systems segment is leading the market with more than 17% revenue share in 2023. The need for ultrasound systems in the diagnostic imaging market has been consistently increasing due to several key factors and trends. Ultrasound, also known as sonography, is a non-invasive imaging technique that uses high-frequency sound waves to create real-time images of the body’s internal structures.

Ongoing technological advancements have led to the development of more compact, lightweight, and user-friendly ultrasound systems. These innovations have expanded the use of ultrasound across various clinical settings. Ultrasound is a standard tool in obstetrics for monitoring fetal development, assessing fetal health, and diagnosing conditions such as ectopic pregnancies and placental abnormalities. In gynecology, it aids in evaluating reproductive organ health.

Echocardiography, a specialized form of ultrasound, is essential in cardiology for assessing heart structure, function, and blood flow. It is widely used in diagnosing and managing heart conditions, including valvular disorders and congenital heart defects. Ultrasound-guided biopsies are instrumental in diagnosing and staging certain cancers, such as breast cancer and thyroid cancer. Ultrasound also aids in monitoring tumor response to treatment.

Diagnostic Imaging Market Analysis by Region

North America is leading the diagnostic imaging market in terms of revenue in 2023 and is projected to experience a compound annual growth rate of 3.4% over the forecast period. The diagnostic imaging market in North America is one of the most mature markets globally. The region is known for its cutting-edge healthcare technologies, a strong emphasis on research and development, and a commitment to providing high-quality healthcare services.

Prominent companies such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems have a significant presence in the North American market, supplying advanced diagnostic imaging equipment and technologies.

Diagnostic Imaging Market Share by Region, 2023 (%)

Diagnostic Imaging Market Share by Region, 2023 (%)

Buy the Full Report for Additional Diagnostic Imaging Market Insights

Download a Free Sample

Asia-Pacific accounted for the second highest share in terms of revenue in 2023 in the DI market. The region is projected to witness moderate growth with a CAGR of around 4% over the forecast period from 2023 to 2033. The Asia-Pacific region’s diagnostic imaging market is characterized by its diversity, rapid growth, and commitment to leveraging advanced technologies to improve healthcare outcomes. With its expanding healthcare infrastructure and a growing focus on early disease detection and prevention, APAC plays a pivotal role in shaping the future of diagnostic imaging on a global scale.

The Asia-Pacific region encompasses a wide spectrum of healthcare systems, from highly developed ones in countries like Japan and Singapore to emerging healthcare markets in parts of Southeast Asia. The sheer size and diversity of the population in the Asia-Pacific makes it a critical market for diagnostic imaging. The region faces unique healthcare challenges, including a rapidly aging population and the burden of non-communicable diseases.

The DI market in China has been gaining significant momentum in recent years. China’s diagnostic imaging market reflects its commitment to enhancing healthcare services, advancing technology, and improving patient care. With its vast healthcare infrastructure, innovative capabilities, and a focus on preventive healthcare, China is poised to continue its significant influence on the global diagnostic imaging landscape.

Diagnostic Imaging Market – Competitive Landscape

The global DI market is highly competitive with several key companies offering DI products and services. The diagnostic imaging market is characterized by companies that are continually adapting to changing dynamics. These changes are driven by the rapid advancement of technology, the introduction of novel imaging methods, and an increasing emphasis on precise diagnostic techniques.

As the demand for advanced diagnostic technologies continues to grow, competition intensifies as companies strive to offer cutting-edge imaging solutions, expand their market presence, and address evolving healthcare needs. For instance, the increasing demand for accurate and non-invasive diagnostic solutions has resulted in market leaders, alongside emerging entrants, engage in strategic collaborations, research and development endeavors, and geographic expansion efforts to maintain their competitive edge in the market.

This vibrant marketplace thrives on innovation, accessibility, and a commitment to improving healthcare outcomes through cutting-edge diagnostic imaging technologies. While industry giants dominate the market, emerging players and startups are injecting fresh perspectives and disruptive technologies into the diagnostic imaging landscape. These agile companies often focus on niche areas, exploring novel imaging modalities or pioneering AI applications.

For instance,

  • Butterfly Network has developed a handheld, pocket-sized ultrasound device that connects to smartphones, democratizing access to ultrasound imaging. Their innovative approach extends beyond conventional healthcare settings, making diagnostic imaging accessible in remote and resource-limited regions.
  • Nanox, an Israeli startup, is revolutionizing X-ray technology by developing a cost-effective, digital X-ray system that promises to make early diagnosis and preventive screening more accessible globally. With its novel approach, Nanox aims to tackle the challenge of limited access in underserved areas.

Leading Companies in the Diagnostic Imaging Market

  • Bayer AG
  • Canon Inc
  • Cardinal Health Inc
  • Fujifilm Holdings Corp
  • GE Healthcare
  • Hologic Inc
  • Koninklijke Philips NV
  • Neusoft Corp
  • Shimadzu Corp
  • Siemens AG

Other Diagnostic Imaging Market Vendors Mentioned

Beijing Pharmaceutical Group Co Ltd, Bracco SpA, Diagnostic Medical Systems SA, DuPont de Nemours Inc (Key Subsidiary of Corteva Inc), Guerbet SA, Hitachi Ltd, Nemoto Kyorindo Co Ltd, Novartis AG, Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd), Ulrich GmbH & Co KG and Ziehm Imaging Gmbh

Buy the Full Report to Know More About Leading Diagnostic Imaging Market Players

Download a Free Sample

Diagnostic Imaging Market Segments and Scope

GlobalData Plc has segmented the diagnostic imaging market report by product type and region:

Diagnostic Imaging Market Product Type Outlook (Revenue, $ Million 2021-2033)

  • Angio Suites
  • Single Plane Angio Suites
  • Biplane Angio Suites
  • Bone Densitometers
  • Dual Energy X-ray Absorptiometry (DEXA)
  • Quantitative Ultrasound (QUS)
  • C-arms
  • Mobile C-arms
  • Fixed C-arms
  • Computed Tomography (CT) Systems
  • 256-320 slice CT Systems
  • 128-slice CT Systems
  • 64-slice CT Systems
  • 20-40 slice CT Systems
  • 16-slice and below CT Systems
  • Contrast Media Injectors
  • Computed Tomography (CT) Injectors
  • Magnetic Resonance Imaging (MRI) Injectors
  • Angiographic Injectors
  • Mammography Equipment
  • 2D Digital Mammography Equipment
  • Breast Tomosynthesis
  • Retrofit Breast Tomosynthesis
  • MRI Systems
  • 3T MRI Systems
  • 5T MRI Systems
  • 2T-1.2T MRI Systems
  • Nuclear Imaging Equipment
  • Positron Emission Tomography (PET) Systems
  • Positron Emission Tomography/Computed Tomography (PET/CT) Systems
  • Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems
  • Single Photon Emission Computed Tomography (SPECT) Systems
  • Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems
  • Ultrasound Systems
  • 2D Ultrasound Systems
  • 3D Ultrasound Systems
  • Real-Time 3D/4D Ultrasound Systems
  • Handheld Ultrasound (HHU) Systems
  • X-ray Systems
  • Computed Radiography (CR) X-ray Systems
  • Direct Digital Radiography (DDR) X-ray Systems
  • Contrast Agents
  • Computed Tomography (CT) Contrast Agents
  • Magnetic Resonance Imaging (MRI) Contrast Agents
  • Ultrasound Contrast Agents (Microbubbles)
  • Nuclear Imaging Agents
  • PET Imaging Agents
  • SPECT Imaging Agents

Diagnostic Imaging Market Regional Outlook (Revenue, $ Million, 2021-2033)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • United Kingdom
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
  • Central & South America
  • Brazil
  • Chile
  • Argentina
  • Middle East & Africa
  • United Arab Emirates
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Scope

  • This report provides overview and service addressable market for global Diagnostic Imaging (DI) market
  • It identifies the key drivers and restraints impacting growth of the DI market over the next 12 to 24 months.
  • It includes global market forecasts for the DI market and reimbursement scenario, and regulatory trends.
  • It covers detailed segmentation by product type – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectorst, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents, along with regional segmentation.

Key Highlights

The global Diagnostic Imaging (DI) market will be valued at $36.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% over the forecast period. The diagnostic imaging market’s future is bright, with technology, patient-centric care, and preventive healthcare at the forefront. This industry will continue to play a crucial role in improving healthcare outcomes and advancing medical science.​ Diagnostic imaging in personalized medicine, helps in tailor treatment plans to individual patient profiles, thereby improving treatment efficacy and reducing adverse effects.​ AI and machine learning will become integral to diagnostic imaging, automating image analysis and expediting diagnosis, thereby improving workflow efficiency.

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global Diagnostic Imaging (DI) market by product type, regional segments in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData’s Forecast products, the report examines the drivers, challenges, and regulatory trend analysis in the DI market.
  • Detailed segmentation by product type – Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectorst, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents, along with vertical and regional segmentation.
  • The report includes 100+ charts and tables providing in-depth analysis of the market size, forecast, and supporting factors which are tailor-made for an executive-level audience, with enhanced presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from local market players, which enables executives to quickly get up to speed with the current and emerging trends in DI markets.
  • The competitive section of the report helps in identifying the flagbearers, experimenters, contenders, and specialists based on their growth and innovation performance in the DI industry which will help stakeholders analyze competition penetration.
  • The broad perspective of the report, coupled with comprehensive, actionable detail, will help DI vendors and other companies succeed in the growing DI market globally.

Table of Contents

  • Chapter 1 Executive Summary
  • Chapter 2 Research Scope and Segmentation

    • 2.1 Diagnostic Imaging (DI): Market Segmentation and Scope
    • 2.2 Diagnostic Imaging (DI): Market Definitions

  • Chapter 3 Diagnostic Imaging (DI) – Industry Trend Analysis

    • 3.1 Diagnostic Imaging (DI) – Market Drivers
    • 3.2 Diagnostic Imaging (DI) – Market Restraints
    • 3.3 Diagnostic Imaging (DI) – Regulatory Landscape
    • 3.4 Diagnostic Imaging (DI) – Reimbursement Trends

  • Chapter 4 Diagnostic Imaging (DI) Global Outlook

    • 4.1 Global Diagnostic Imaging (DI) Market – Revenue Snapshot ($M)
    • 4.2 Global Diagnostic Imaging (DI): Detailed Market Size Estimates($M)
    • 4.3 Global Diagnostic Imaging (DI) Revenue Opportunity by Product Type($M)
    • 4.4 Global Diagnostic Imaging (DI) Market – By Region, 2021-2033 ($M)

  • Chapter 5 Diagnostic Imaging (DI) Regional Outlook

    • 5.1 Diagnostic Imaging (DI) – Regional Overview & Analysis
    • 5.2 North America Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

      • 5.2.1 North America Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
      • 5.2.2 US Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.2.2.1 US Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.2.3 Canada Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.2.3.1 Canada Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.2.4 Mexico Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.2.4.1 Mexico Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

    • 5.3 Europe Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

      • 5.3.1 Europe Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
      • 5.3.2 France Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.2.1 France Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.3.3 Germany Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.3.1 Germany Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.3.4 Italy Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.4.1 Italy Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.3.5 Spain Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.5.1 Spain Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.3.6 The Netherlands Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.6.1 The Netherlands Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.3.7 Switzerland Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.7.1 Switzerland Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.3.8 UK Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.8.1 UK Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.3.9 Rest of Europe Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.3.9.1 Rest of Europe Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

    • 5.4 Asia Pacific Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

      • 5.4.1 Asia Pacific Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
      • 5.4.2 China Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.4.2.1 China Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.4.3 India Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.4.3.1 India Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.4.4 Japan Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.4.4.1 Japan Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.4.5 Australia Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.4.5.1 Australia Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.4.6 Rest of Asia-Pacific Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.4.6.1 Rest of Asia-Pacific Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

    • 5.5 South & Central America Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

      • 5.5.1 South & Central America Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
      • 5.5.2 Argentina Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.5.2.1 Argentina Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.5.3 Brazil Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.5.3.1 Brazil Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.5.4 Chile Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.5.4.1 Chile Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

    • 5.6 Middle East & Africa Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

      • 5.6.1 Middle East & Africa Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
      • 5.6.2 United Arab Emirates Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.6.2.1 United Arab Emirates Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.6.3 Saudi Arabia Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.6.3.1 Saudi Arabia Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.6.4 South Africa Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.6.4.1 South Africa Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

      • 5.6.5 Rest of Middle East & Africa Diagnostic Imaging (DI) Market – Overview, 2021-2033 ($M)

        • 5.6.5.1 Rest of Middle East & Africa Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

  • Chapter 6 Competitive Landscape

    • 6.1 Diagnostic Imaging: Competitive Landscape Overview
    • 6.2 Diagnostic Imaging: Company Share Analysis

  • Chapter 7 Company Profiles

    • 7.1 Bayer AG: Overview

      • 7.1.1 Bayer AG: DI Offerings
      • 7.1.2 Bayer AG: Financials
      • 7.1.3 Bayer AG: SWOT Analysis
      • 7.1.4 Bayer AG: Key Personnel

    • 7.2 Beijing Pharmaceutical Group Co Ltd: Overview

      • 7.2.1 Beijing Pharmaceutical Group Co Ltd: DI Offerings
      • 7.2.2 Beijing Pharmaceutical Group Co Ltd: Key Personnel

    • 7.3 Bracco SpA: Overview

      • 7.3.1 Bracco SpA: DI Offerings
      • 7.3.2 Bracco SpA: SWOT Analysis
      • 7.3.3 Bracco SpA: Key Personnel

    • 7.4 Canon Inc: Overview

      • 7.4.1 Canon Inc: DI Offerings
      • 7.4.2 Canon Inc: Financials
      • 7.4.3 Canon Inc: SWOT Analysis
      • 7.4.4 Canon Inc: Key Personnel

    • 7.5 Cardinal Health Inc: Overview

      • 7.5.1 Cardinal Health Inc: DI Offerings
      • 7.5.2 Cardinal Health Inc: Financials
      • 7.5.3 Cardinal Health Inc: SWOT Analysis
      • 7.5.4 Cardinal Health Inc: Key Personnel

    • 7.6 Diagnostic Medical Systems SA: Overview

      • 7.6.1 Diagnostic Medical Systems SA: DI Offerings
      • 7.6.2 Diagnostic Medical Systems SA: Financials
      • 7.6.3 Diagnostic Medical Systems SA: Key Personnel

    • 7.7 Fujifilm Holdings Corp: Overview

      • 7.7.1 Fujifilm Holdings Corp: DI Offerings
      • 7.7.2 Fujifilm Holdings Corp: Financials
      • 7.7.3 Fujifilm Holdings Corp: SWOT Analysis
      • 7.7.2 Fujifilm Holdings Corp: Key Personnel

    • 7.8 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): Overview

      • 7.8.1 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): DI Offerings
      • 7.8.2 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): Financials
      • 7.8.3 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): SWOT Analysis
      • 7.8.4 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): Key Personnel

    • 7.9 Guerbet SA: Overview

      • 7.9.1 Guerbet SA: DI Offerings
      • 7.9.2 Guerbet SA: Financials
      • 7.9.3 Guerbet SA: SWOT Analysis
      • 7.9.4 Guerbet SA: Key Personnel

    • 7.10 GE Healthcare: Overview

      • 7.10.1 GE Healthcare: DI Offerings
      • 7.10.2 GE Healthcare: Financials
      • 7.10.3 GE Healthcare: SWOT Analysis
      • 7.10.4 GE Healthcare: Key Personnel

    • 7.11 Hitachi Ltd: Overview

      • 7.11.1 Hitachi Ltd: DI Offerings
      • 7.11.2 Hitachi Ltd: Financials
      • 7.11.3 Hitachi Ltd: SWOT Analysis
      • 7.11.4 Hitachi Ltd: Key Personnel

    • 7.12 Hologic Inc: Overview

      • 7.12.1 Hologic Inc: DI Offerings
      • 7.12.2 Hologic Inc: Financials
      • 7.12.3 Hologic Inc: SWOT Analysis
      • 7.12.4 Hologic Inc: Key Personnel

    • 7.13 Nemoto Kyorindo Co Ltd: Overview

      • 7.13.1 Nemoto Kyorindo Co Ltd: DI Offerings
      • 7.13.2 Nemoto Kyorindo Co Ltd: Key Personnel

    • 7.14 Koninklijke Philips NV: Overview

      • 7.14.1 Koninklijke Philips NV: DI Offerings
      • 7.14.2 Koninklijke Philips NV: Financials
      • 7.14.3 Koninklijke Philips NV: SWOT Analysis
      • 7.14.4 Koninklijke Philips NV: Key Personnel

    • 7.15 Neusoft Corp.: Overview

      • 7.15.1 Neusoft Corp: DI Offerings
      • 7.15.2 Neusoft Corp: Financials
      • 7.15.3 Neusoft Corp: SWOT Analysis
      • 7.15.4 Neusoft Corp: Key Personnel

    • 7.16 Novartis AG: Overview

      • 7.16.1 Novartis AG: DI Offerings
      • 7.16.2 Novartis AG: Financials
      • 7.16.3 Novartis AG: SWOT Analysis
      • 7.16.4 Novartis AG: Key Personnel

    • 7.17 Shimadzu Corp: Overview

      • 7.17.1 Shimadzu Corp: DI Offerings
      • 7.17.2 Shimadzu Corp: Financials
      • 7.17.3 Shimadzu Corp: SWOT Analysis
      • 7.17.4 Shimadzu Corp: Key Personnel

    • 7.18 Siemens AG: Overview

      • 7.18.1 Siemens AG: DI Offerings
      • 7.18.2 Siemens AG: Financials
      • 7.18.3 Siemens AG: SWOT Analysis
      • 7.18.4 Siemens AG: Key Personnel

    • 7.19 Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd).: Overview

      • 7.19.1 Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd): Financials

    • 7.20 Ulrich GmbH & Co KG: Overview

      • 7.20.1 Ulrich GmbH & Co KG: DI Offerings
      • 7.20.2 Ulrich GmbH & Co KG: Key Personnel

    • 7.21 Ziehm Imaging Gmbh: Overview

      • 7.21.1 Ziehm Imaging Gmbh: DI Offerings
      • 7.21.2 Ziehm Imaging Gmbh: Key Personnel

  • Chapter 10 Research Methodology
  • Chapter 11 About GlobalData

Table

Table 1: Table: Diagnostic Imaging – Regulatory landscape (Top 5 countries)

Table 2: Diagnostic Imaging – Reimbursement Scenario (Top 5 countries)

Table 3: Diagnostic Imaging Market Revenue, by Product Type ($M), 2021-2033

Table 4: Global DI Market by Region ($M), 2021-2033

Table 5: Bayer AG Diagnostic Imaging Offerings

Table 6: Bayer AG Key Personnel

Table 7: Beijing Pharmaceutical Group Co Ltd Diagnostic Imaging Offerings

Table 8: Beijing Pharmaceutical Group Co Ltd Key Personnel

Table 9: Bracco SpA Imaging Offerings

Table 10: Bracco SpA Key Personnel

Table 11: Canon Inc Diagnostic Imaging Offerings

Table 12: Canon Inc Key Personnel

Table 13: Cardinal Health Inc Diagnostic Imaging Offerings

Table 14: Cardinal Health Inc Key Personnel

Table 15: Diagnostic Medical Systems SA Diagnostic Imaging Offerings

Table 16: Diagnostic Medical Systems SA Key Personnel

Table 17: DuPont de Nemours Inc (Key Subsidiary of Corteva Inc) Diagnostic Imaging Offerings

Table 18: DuPont de Nemours Inc (Key Subsidiary of Corteva Inc) Key Personnel

Table 19: Fujifilm Holdings Corp Diagnostic Imaging Offerings

Table 20: Fujifilm Holdings Corp Key Personnel

Table 21: GE Healthcare Diagnostic Imaging Offerings

Table 22: GE Healthcare Key Personnel

Table 23: Guerbet SA Diagnostic Imaging Offerings

Table 24: Guerbet SA Key Personnel

Table 25: Hitachi Ltd Diagnostic Imaging Offerings

Table 26: Hitachi Ltd Key Personnel

Table 27: Hologic Inc Diagnostic Imaging Offerings

Table 28: Hologic Inc Key Personnel

Table 29: Koninklijke Philips NV Diagnostic Imaging Offerings

Table 30: Koninklijke Philips NV Key Personnel

Table 31: Nemoto Kyorindo Co Ltd Diagnostic Imaging Offerings

Table 32: Nemoto Kyorindo Co Ltd Key Personnel

Table 33: Neusoft Corp Diagnostic Imaging Offerings

Table 34: Neusoft Corp Key Personnel

Table 35: Novartis AG Diagnostic Imaging Offerings

Table 36: Novartis AG Key Personnel

Table 37: Shimadzu Corp Diagnostic Imaging Offerings

Table 38: Shimadzu Corp Key Personnel

Table 39: Siemens AG Diagnostic Imaging Offerings

Table 40: Siemens AG Key Personnel

Table 41: Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd) Diagnostic Imaging Offerings

Table 42: Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd) Key Personnel

Table 43: Ulrich GmbH & Co KG Diagnostic Imaging Offerings

Table 44: Ulrich GmbH & Co KG Key Personnel

Table 45: Ziehm Imaging Gmbh Diagnostic Imaging Offerings

Table 46: Ziehm Imaging Gmbh Key Personnel

Table 47: Perry Baromedical Diagnostic Imaging Offerings

Table 48: Haux-Life-Support Diagnostic Imaging Offerings

Figures

Fig 1: Key Diagnostic Imaging (DI) Country Markets ($B), 2022 vs 2033

Fig 2: Diagnostic Imaging (DI) Market by Region, 2022 ($M)

Fig 3: Global Diagnostic Imaging Market Size & Forecasts ($M), 2021-2033

Fig 4: Global Diagnostic Imaging Market Size & Forecasts by Product Type ($M), 2021-2033

Fig 5: Global DI Market Estimates ($M) & CAGR (%), By Region (2023 vs 2033)

Fig 6: DI Regional Overview ($M), 2023 & 2033

Fig 7: North America Diagnostic Imaging Market ($M), 2021-2033

Fig 8: North America DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 9: US DI Market ($M), 2021-2033

Fig 10: US DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 11: Canada DI Market ($M), 2021-2033

Fig 12: Canada DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 13: Mexico DI Market ($M), 2021-2033

Fig 14: Mexico DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 15: Europe Diagnostic Imaging Market ($M), 2021-2033

Fig 16: Europe DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 17: France DI Market ($M), 2021-2033

Fig 18: France DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 19: Germany DI Market ($M), 2021-2033

Fig 20: Germany DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 21: Italy DI Market ($M), 2021-2033

Fig 22: Italy DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 23: Spain DI Market ($M), 2021-2033

Fig 24: Spain DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 25: United Kingdom DI Market ($M), 2021-2033

Fig 26: United Kingdom DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 27: Switzerland DI Market ($M), 2021-2033

Fig 28: Switzerland DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 29: The Netherlands DI Market ($M), 2021-2033

Fig 30: The Netherlands DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 31: Rest of Europe DI Market ($M), 2021-2033

Fig 32: Rest of Europe DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 33: Asia-Pacific Diagnostic Imaging Market ($M), 2021-2033

Fig 34: Asia-Pacific DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 35: China DI Market ($M), 2021-2033

Fig 36: China DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 37: India DI Market ($M), 2021-2033

Fig 38: India DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 39: Japan DI Market ($M), 2021-2033

Fig 40: Japan DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 41: Australia DI Market ($M), 2021-2033

Fig 42: Australia DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 43: Rest of Asia-Pacific DI Market ($M), 2021-2033

Fig 44: Rest of Asia-Pacific DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 45: South and Central America Diagnostic Imaging Market ($M), 2021-2033

Fig 46: South and Central America DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 47: Argentina DI Market ($M), 2021-2033

Fig 48: Argentina DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 49: Brazil DI Market ($M), 2021-2033

Fig 50: Brazil DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 51: Chile DI Market ($M), 2021-2033

Fig 52: Chile DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 53: Middle East and Africa Diagnostic Imaging Market ($M), 2021-2033

Fig 54: Middle East and Africa DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 55: United Arab Emirates DI Market ($M), 2021-2033

Fig 56: United Arab Emirates DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 57: Saudi Arabia DI Market ($M), 2021-2033

Fig 58: Saudi Arabia DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 59: South Africa DI Market ($M), 2021-2033

Fig 60: South Africa DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 61: Rest of MEA DI Market ($M), 2021-2033

Fig 62: Rest of MEA DI Market Size & Forecasts by Product Type($M), 2021-2033

Fig 63: Ultrasound Systems Key Players Market Share in 2022

Fig 64: Computed Tomography (CT) Systems Key Players Market Share in 2022

Fig 65: MRI Systems Key Players Market Share in 2022

Fig 66: Contrast Agents Key Players Market Share in 2022

Fig 67: X-ray Systems Key Players Market Share in 2022

Fig 68: Nuclear Imaging Equipment Key Players Market Share in 2022

Fig 69: Angio Suites Key Players Market Share in 2022

Fig 70: Mammography Equipment Key Players Market Share in 2022

Fig 71: C-Arms Key Players Market Share in 2022

Fig 72: Contrast Media Injectors Key Players Market Share in 2022

Fig 73: Nuclear Imaging Agents Key Players Market Share in 2022

Fig 74: Bone Densitometers Key Players Market Share in 2022

Fig 75: Bayer AG Financial Performance (EUR Million)

Fig 76: Canon Inc Financial Performance (JPY Million)

Fig 77: Cardinal Health Inc (USD Million)

Fig 78: Diagnostic Medical Systems SA Financial Performance (EUR Million)

Fig 79: DuPont de Nemours Inc (Key Subsidiary of Corteva Inc) Financial Performance (USD Million)

Fig 80: Fujifilm Holdings Corp Financial Performance (JPY Million)

Fig 81: GE Healthcare Financial Performance (USD Million)

Fig 82: Guerbet SA Financial Performance (EUR Million)

Fig 83: Hitachi Ltd Financial Performance (JPY Million)

Fig 84: Hologic Inc Financial Performance (USD Million)

Fig 85: Koninklijke Philips NV Financial Performance (EUR Million)

Fig 86: Neusoft Corp Financial Performance (CNY Million)

Fig 87: Novartis AG Financial Performance (USD Million)

Fig 88: Shimadzu Corp Financial Performance (JPY Million)

Fig 89: Siemens AG Financial Performance (EUR Million)

Fig 90: Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd) Financial Performance (TWD Million)

Fig 91: Research Methodology Steps

Fig 92: Core Objectives of the Market Study

Fig 93: Research Approach

Fig 94: Analysis Flow

Fig 95: Quality Control Flow

Frequently asked questions

  • What is the global diagnostic imaging market size in 2023?

    The global DI market size will be valued at $36.5 billion in 2023.

  • What is the diagnostic imaging market growth rate?

    The global DI market is expected to grow at a CAGR of 4.2% over the forecast period (2023-2033).

  • What is the key DI market driver?

    Advancements in imaging technology stand as a prominent driver propelling the growth and transformation of the diagnostic imaging market. Rapid developments in medical imaging techniques, modalities, and equipment are revolutionizing healthcare by enhancing diagnostic accuracy, enabling early disease detection, and facilitating more personalized treatment strategies.

  • What are the key DI market segments?

    Product segment – Angio suites, bone densitometers, c-arms, computed tomography (CT) systems, CT systems, contrast media injectors, mammography equipment, MRI systems, nuclear imaging equipment, ultrasound systems, x-ray systems, contrast agents, and nuclear imaging agents.

    Regional segment – North America, Europe, Asia-Pacific, South & Central America, and Middle East & Africa

  • Which are the leading DI companies globally?

    The leading DI companies are Bayer AG, Canon Inc, Cardinal Health Inc, Fujifilm Holdings Corp, GE Healthcare, Hologic Inc, Koninklijke Philips NV, Neusoft Corp, Shimadzu Corp, and Siemens AG.

  • Is there a third level of segmentation in the report?

    GlobalData’s focus is on providing reliable and accurate data that is supported by robust research methodology. Our reports undergo rigorous quality checks and are based on primary and secondary research sources, ensuring that the numbers and insights provided are trustworthy. However, despite the best efforts to gather comprehensive data, there could be instances where the available data is limited, making it challenging to provide third-level segmentation. In such cases, GlobalData may choose to provide high-level insights and general trends rather than forcing segmentation that may not be backed by sufficient data. This approach ensures that the report’s overall quality and credibility are maintained.

Currency USD
$3,950

Can be used by individual purchaser only

$7,950

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

We are confident about Diagnostic Imaging (DI) Market Size, Share, Trends and Analysis by Product Type, Region and Segment Forecast to 2033 report's unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Diagnostic Imaging (DI) Market Size, Share, Trends and Analysis by Product Type, Region and Segment Forecast to 2033 in real time.

  • Access a live Diagnostic Imaging (DI) Market Size, Share, Trends and Analysis by Product Type, Region and Segment Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.